News for AKCA Stock

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020 Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020 Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020 Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020 Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany Akcea Therapeutics to Hold Second Quarter 2020 Financial Results Webcast Akcea Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference Akcea Appoints New Senior Vice President, Global Medical Affairs